Enhertu significantly improved IDFS compared to Kadcyla, with a 53% risk reduction in invasive disease or death in high-risk, ...
Merck’s efforts to make headway in a cancer type that was an elusive target for its superstar oncology med Keytruda proves to ...
This Diwali, I received a big surprise from Nothing India, a beautiful gift box that I wasn’t expecting at all. It all started when I got a delivery call while I was half asleep. I hadn’t ordered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results